Fintel reports that on July 24, 2025, Baird upgraded their outlook for ICON Public Limited (NasdaqGS:ICLR) from Neutral to ...

ICON Public Limited Company (ICLR)’s share was trading at $145 as of April 28th. ICLR’s trailing and forward P/E were 15.22 and 10.20 respectively according to Yahoo Finance. ICON, […] ...

ICON Public Limited Company’s (NASDAQ:ICLR) third quarter revenue was $2.03 billion, represents a year-on-year decrease of 1.2% or 1% on a constant currency basis.

ICON Public Limited Company (NASDAQ:ICLR) Q3 2024 Earnings Conference Call October 24, 2024 8:00 AM ET. ... On the development model changes in the replenishment cycle, ...

Icon has historically maintained a fairly conservative balance sheet. It ended 2023 with $380 million in cash and cash equivalents. The company ended the fourth quarter of 2023 with a net debt ...

ICON Public Limited Company (NASDAQ:ICLR) is a global contract research organization that provides development and commercialization services to pharmaceutical companies.

ICON Public Limited Company (NASDAQ:ICLR) Q1 2025 Earnings Call Transcript May 1, 2025 8:00 AM ETCompany ParticipantsKate Haven - Vice President, Investor ...